Management of antiretroviral therapy

Keyphrases

• Antiretroviral Therapy 100%
• Antiviral Drugs 100%
• Inappropriate Use 100%
• Nucleoside Reverse Transcriptase Inhibitors 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 50%
• Patient Management 50%
• AIDS/HIV 50%
• Clinical Trials 50%
• Viral RNA Levels 50%
• New Drugs 50%
• Protease Inhibitors 50%
• New Antivirals 50%
• Treating Physicians 50%
• Drug Interactions 50%
• Drug Regimen 50%
• Pharmacokinetics 50%
• General Guidelines 50%
• Novel Class 50%
• Approved Drugs 50%
• Quantitative Assay 50%
• Multidrug Regimen 50%
• Unique Properties 50%
• Long-term Tolerance 50%
• Viral Burden 50%
• Antiviral Properties 50%
• Toxic Interaction 50%
• Unnatural nucleotides 50%
• Long-term Compliance 50%
• Time Availability 50%
• Broad Dynamic Range 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Antivirus Agent 100%
• RNA Directed DNA Polymerase Inhibitor 100%
• Nucleoside Analog 100%
• HIV 50%
• Combination Drug 50%
• Clinical Trial 50%
• Human Immunodeficiency Virus 1 50%
• Proteinase Inhibitor 50%
• Pharmacokinetics 50%
• Virus RNA 50%
• Drug Interaction 50%